Author

B. J. Davis

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biophysics· 1 Cancer Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Research Focus:cell signaling & trafficking· 2 Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:drug response / drug discovery· 1 Assay:fluorescence / live-cell microscopy· 1

Frequent Co-Authors

B. K. Law· 2 shared C. D. Heldermon· 2 shared E. Yaaghubi· 2 shared M. E. Law· 2 shared R. K. Castellano· 2 shared A. A. Klammer· 1 shared A. B. Heckert· 1 shared A. Driouchi· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

B. K. Law

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Oblique Line Scan Illumination Enables Expansive, Accurate and Sensitive Single Protein Measurements in Solution and in Living Cells

A. Driouchi, M. Bretan, B. J. Davis, A. B. Heckert, M. Seeger, M. Bradley Silva, W. S. Forrest, J. Hsiung, J. Tan, H. Yang, D. T. McSwiggen, L. Song, A. Sule, B. Abaie, B. Conroy, , D. J. Anderson

This paper introduces Oblique Line Scan (OLS) illumination to enhance single-molecule tracking in living cells and solution, enabling high-throughput and sensitive protein dynamics measurements.

bioRxiv · Dec 21, 2023Biophysics

Repurposing Tranexamic Acid as an Anticancer Agent

M. E. Law, B. J. Davis, A. F. Ghilardi, E. Yaaghubi, Z. M. Dulloo, M. Wang, O. Guryanova, C. D. Heldermon, R. K. Castellano, B. K. Law

This study shows Tranexamic Acid inhibits cancer growth by blocking Plasmin-mediated CDCP1 cleavage and disrupts multiple intracellular signaling pathways.

bioRxiv · Oct 17, 2021 · PreprintCancer Biology

Inhibitors of ERp44, PDIA1, and AGR2 induce disulfide-mediated oligomerization of Death Receptors 4 and 5 and cancer cell death

M. E. Law, E. Yaaghubi, A. Ghilardi, B. J. Davis, R. B. Ferreira, J. Koh, S. Chen, S. F. DePeter, C. M. Schilson, C.-W. Chiang, C. D. Heldermon, P. Norgaard, R. K. Castellano, B. K. Law

This study identifies DDAs as inhibitors of AGR2 and ERp44, showing they induce DR4/5 oligomerization and cancer cell death via disrupting disulfide bonds.

bioRxiv · Jan 13, 2021Pharmacology & Toxicology